The combination of CRP isoforms with oxLDL decreases TNF-α and IL-6 release by U937-derived macrophages

Biomedical Reports

Volumn 7, Issue 3, 2017, Pages 272-276

  Krayem, Imtissal ^a   Bazzi, Samer ^a   Karam, Dmarc ^a  

^a UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

CRP isoforms; Cytokines; Inflammation; Macrophages; OxLDL

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL VIABILITY; CENTRIFUGATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; POLYACRYLAMIDE GEL ELECTROPHORESIS; U-937 CELL LINE;

EID: 85040072242     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2017.949     Document Type: Article

References (34)

1. Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, Lozano R and Moran AE: Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res 46: 328-338, 2015.
2. Hattori Y, Matsumura M and Kasai K: Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58: 186-195, 2003.
3. Eisenhardt SU, Thiele JR, Bannasch H, Stark GB and Peter K: C-reactive protein: How conformational changes influence inflammatory properties. Cell Cycle 8: 3885-3892, 2009.
4. Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, Qian H, von Zur Muhlen C, Hagemeyer CE, Ahrens I, et al: Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 105: 128-137, 2009.
5. Khreiss T, József L, Potempa LA and Filep JG: Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109: 2016-2022, 2004.
6. Schwedler SB, Amann K, Wernicke K, Krebs A, Nauck M, Wanner C, Potempa LA and Galle J: Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation 112: 1016-1023, 2005.
7. Eisenhardt SU, Habersberger J and Peter K: Monomeric C-reactive protein generation on activated platelets: The missing link between inflammation and atherothrombotic risk. Trends Cardiovasc Med 19: 232-237, 2009.
8. Filep JG: Platelets affect the structure and function of C-reactive protein. Circ Res 105: 109-111, 2009.
9. Khreiss T, József L, Potempa LA and Filep JG: Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 97: 690-697, 2005.
10. Libby P, Ridker PM and Maseri A: Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
11. Tabuchi M, Inoue K, Usui-Kataoka H, Kobayashi K, Teramoto M, Takasugi K, Shikata K, Yamamura M, Ando K, Nishida K, et al: The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. J Lipid Res 48: 768-781, 2007.
12. Chang MK, Hartvigsen K, Ryu J, Kim Y and Han KH: The pro-atherogenic effects of macrophages are reduced upon formation of a complex between C-reactive protein and lysophos-phatidylcholine. J Inflamm (Lond) 9: 42, 2012.
13. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U and Hansson GK: Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145: 33-43, 1999.
14. Qiu G, Ho AC, Yu W and Hill JS: Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion. J Lipid Res 48: 385-394, 2007.
15. Jovinge S, Ares MP, Kallin B and Nilsson J: Human mono-cytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16: 1573-1579, 1996.
16. Eruslanov E and Kusmartsev S: Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 594: 57-72, 2010.
17. Uzui H, Harpf A, Liu M, Doherty TM, Shukla A, Chai NN, Tripathi PV, Jovinge S, Wilkin DJ, Asotra K, et al: Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: Role of activated macrophages and inflammatory cytokines. Circulation 106: 3024-3030, 2002.
18. Kaneto H, Katakami N, Matsuhisa M and Matsuoka TA: Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010: 453892, 2010.
19. Chávez-Sánchez L, Chávez-Rueda K, Legorreta-Haquet MV, Zenteno E, Ledesma-Soto Y, Montoya-Díaz E, Tesoro-Cruz E, Madrid-Miller A and Blanco-Favela F: The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1beta, IL-6, and IL-10 secretion in human monocytes and macrophages. Lipids Health Dis 9: 117, 2010.
20. Galve-de Rochemonteix B, Wiktorowicz K, Kushner I and Dayer JM: C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha and expression of mRNA by human alveolar macrophages. J Leukoc Biol 53: 439-445, 1993.
21. Pue CA, Mortensen RF, Marsh CB, Pope HA and Wewers MD: Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. J Immunol 156: 1594-1600, 1996.
22. Gershov D, Kim S, Brot N and Elkon KB: C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflam-matory innate immune response: Implications for systemic autoimmunity. J Exp Med 192: 1353-1364, 2000.
23. Taylor KE and van den Berg CW: Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein. Immunology 120: 404-411, 2007.
24. Adan A, Kiraz Y and Baran Y: Cell proliferation and cytotoxicity assays. Curr Pharm Biotechnol 17: 1213-1221, 2016.
25. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P and Pedersen BK: A high plasma concentration of TNF-αlpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54: M357-M364, 1999.
26. Hansson GK and Hermansson A: The immune system in atherosclerosis. Nat Immunol 12: 204-212, 2011.
27. Devaraj S, Davis B, Simon SI and Jialal I: CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol 291: H1170-H1176, 2006.
28. Bruunsgaard H, Skinhøj P, Pedersen AN, Schroll M and Pedersen BK: Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol 121: 255-260, 2000.
29. Huber SA, Sakkinen P, Conze D, Hardin N and Tracy R: Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19: 2364-2367, 1999.
30. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J and Jovinge S: Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24: 2137-2142, 2004.
31. Hansson GK and Libby P: The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 6: 508-519, 2006.
32. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N and Matsushima K: Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56: 559-564, 1994.
33. Zhao XQ, Zhang MW, Wang F, Zhao YX, Li JJ, Wang XP, Bu PL, Yang JM, Liu XL, Zhang MX, et al: CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res 52: 923-933, 2011.
34. Thiele JR, Zeller J, Bannasch H, Stark GB, Peter K and Eisenhardt SU: Targeting C-reactive protein in inflammatory disease by preventing conformational changes. Mediators Inflamm 2015: 372432, 2015.